PT950657E - Carbazoles substituidos, processo para a sua preparacao, e sua utilizacao como inibidores de spla2 - Google Patents

Carbazoles substituidos, processo para a sua preparacao, e sua utilizacao como inibidores de spla2

Info

Publication number
PT950657E
PT950657E PT99302967T PT99302967T PT950657E PT 950657 E PT950657 E PT 950657E PT 99302967 T PT99302967 T PT 99302967T PT 99302967 T PT99302967 T PT 99302967T PT 950657 E PT950657 E PT 950657E
Authority
PT
Portugal
Prior art keywords
preparation
spla2 inhibitors
substituted carbazoles
carbazoles
substituted
Prior art date
Application number
PT99302967T
Other languages
English (en)
Inventor
Gary Alan Hite
Daniel Jon Sall
Nicholas James Bach
Robert Theodore Vasileff
Michael Dean Kinnick
John Michael Morin Jr
Jolie Anne Bastian
Edward David Mihelich
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT950657E publication Critical patent/PT950657E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99302967T 1998-04-17 1999-04-16 Carbazoles substituidos, processo para a sua preparacao, e sua utilizacao como inibidores de spla2 PT950657E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6232898A 1998-04-17 1998-04-17

Publications (1)

Publication Number Publication Date
PT950657E true PT950657E (pt) 2004-11-30

Family

ID=22041763

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99302967T PT950657E (pt) 1998-04-17 1999-04-16 Carbazoles substituidos, processo para a sua preparacao, e sua utilizacao como inibidores de spla2

Country Status (30)

Country Link
EP (2) EP0950657B1 (pt)
JP (2) JP4435330B2 (pt)
KR (2) KR100586761B1 (pt)
CN (1) CN1149193C (pt)
AR (2) AR018593A1 (pt)
AT (2) ATE271037T1 (pt)
AU (2) AU753547B2 (pt)
BR (2) BR9902365A (pt)
CA (2) CA2269246C (pt)
CO (2) CO5031247A1 (pt)
CZ (2) CZ136999A3 (pt)
DE (2) DE69917833T2 (pt)
DK (1) DK0950657T3 (pt)
DZ (1) DZ2769A1 (pt)
EA (2) EA002347B1 (pt)
ES (2) ES2222663T3 (pt)
HU (2) HUP9901220A3 (pt)
ID (2) ID23287A (pt)
IL (2) IL129483A0 (pt)
NO (2) NO314400B1 (pt)
NZ (3) NZ507564A (pt)
PE (2) PE20000476A1 (pt)
PL (2) PL332566A1 (pt)
PT (1) PT950657E (pt)
SG (2) SG81976A1 (pt)
SI (1) SI0950657T1 (pt)
TR (2) TR199900843A2 (pt)
TW (1) TWI238160B (pt)
YU (2) YU19199A (pt)
ZA (2) ZA992771B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301586A1 (en) * 1997-08-28 1999-03-04 William Louis Macias Method for treatment of non-rheumatoid arthritis
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
AU1940800A (en) * 1998-12-21 2000-07-12 Eli Lilly And Company Combination therapy for the treatment of sepsis
CA2379208A1 (en) * 1999-07-19 2001-01-25 Eli Lilly & Company Spla2 inhibitors
US6706752B1 (en) 1999-07-19 2004-03-16 Eli Lilly And Company sPLA2 inhibitors
AU2001267826A1 (en) * 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Remedies for alzheimer's disease
WO2002000256A1 (fr) * 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedes contre la cirrhose
WO2002000255A1 (en) * 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedies for cancer
EP1303262A2 (en) * 2000-07-14 2003-04-23 Eli Lilly And Company Use of a spla2 inhibitor for the treatment of sepsis
US6872743B2 (en) 2000-12-18 2005-03-29 Eli Lilly And Company sPLA2 inhibitors
US6933313B2 (en) 2001-03-28 2005-08-23 Eli Lilly And Company Substituted carbazoles as inhibitors of sPLA2
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
DE10249055A1 (de) 2002-10-22 2004-05-06 Bayer Cropscience Ag 2-Phenyl-2-substituierte-1,3-diketone
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP1988098A1 (en) * 2007-04-27 2008-11-05 AEterna Zentaris GmbH Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
CA2719721C (en) 2008-03-26 2012-12-18 Daiichi Sankyo Company, Limited Tetrahydroisoquinoline derivative
AU2009233711B2 (en) 2008-04-09 2015-02-12 Infinity Pharmaceuticals, Inc Inhibitors of fatty acid amide hydrolase
US8580795B2 (en) 2009-01-22 2013-11-12 Orchid Chemicals & Pharmaceuticals Limited Heterocyclic compounds as phosphodiesterase inhibitors
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
EP2416660B1 (en) 2009-04-07 2014-07-02 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
EP2531511A1 (en) 2010-02-03 2012-12-12 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
CN102816107B (zh) * 2012-08-20 2015-06-03 东南大学 咔唑衍生物及其制备方法与用途
CN104797559A (zh) * 2012-11-30 2015-07-22 通用电气健康护理有限公司 卤化锌介导的环化过程得到三环吲哚
CN111362863A (zh) 2012-11-30 2020-07-03 通用电气健康护理有限公司 三环吲哚衍生物的结晶方法
EP3248230B1 (de) * 2015-01-20 2020-05-06 cynora GmbH Verwendung organischer moleküle in optoelektronischen bauelementen
CN108707104A (zh) * 2018-08-07 2018-10-26 北京恒信卓元科技有限公司 2-氯-1h-咔唑-1,4(9h)-二酮的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579534A (en) * 1969-05-09 1971-05-18 American Cyanamid Co Tetrahydrocarbazolecarboxylates
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
WO1993001169A2 (en) * 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
CA2179678A1 (en) * 1995-06-23 1996-12-24 Michael Edward Flaugh 6-substituted-1,2,3,4-tetrahydro-9h-carbazoles and 7-substituted-10h-cyclohepta¬7,6-b| indoles
US6160175A (en) * 1995-12-13 2000-12-12 Eli Lilly And Company Naphthyl acetamides as sPLA2 inhibitors
KR20000049210A (ko) * 1996-10-30 2000-07-25 피터 지. 스트링거 치환된 트리시클릭류
CA2304482A1 (en) * 1997-09-26 1999-04-08 Eli Lilly And Company Method for the treatment of cystic fibrosis
CA2310250A1 (en) * 1997-11-14 1999-05-27 August Masaru Watanabe Treatment for alzheimer's disease
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.

Also Published As

Publication number Publication date
CA2269246C (en) 2009-08-25
AU753436B2 (en) 2002-10-17
BR9902365A (pt) 2001-04-24
PL332566A1 (en) 1999-10-25
IL129485A0 (en) 2000-02-29
EA199900301A3 (ru) 2000-04-24
YU18999A (sh) 2002-08-12
EA199900303A2 (ru) 1999-10-28
EP0952149A2 (en) 1999-10-27
ATE268756T1 (de) 2004-06-15
NO991822L (no) 1999-10-18
CO5031247A1 (es) 2001-04-27
AU753547B2 (en) 2002-10-24
CA2269246A1 (en) 1999-10-17
EP0950657B1 (en) 2004-07-14
HUP9901221A3 (en) 2001-11-28
DE69917833T2 (de) 2005-07-14
EA002816B1 (ru) 2002-10-31
CN1253948A (zh) 2000-05-24
NO991822D0 (no) 1999-04-16
NZ507564A (en) 2002-10-25
HUP9901220A3 (en) 2001-11-28
PE20000432A1 (es) 2000-05-23
NO991821D0 (no) 1999-04-16
AU2381799A (en) 1999-10-28
SI0950657T1 (en) 2005-02-28
PL332565A1 (en) 1999-10-25
JP2000026416A (ja) 2000-01-25
HU9901221A (hu) 2000-04-28
NZ335253A (en) 2000-11-24
CN1149193C (zh) 2004-05-12
DE69917833D1 (de) 2004-07-15
ES2222663T3 (es) 2005-02-01
ATE271037T1 (de) 2004-07-15
JP4435330B2 (ja) 2010-03-17
ES2226286T3 (es) 2005-03-16
EP0952149A3 (en) 2001-08-16
DE69918590T2 (de) 2005-07-21
NO312240B1 (no) 2002-04-15
TR199900853A3 (tr) 1999-11-22
AU2381999A (en) 1999-10-28
IL129483A0 (en) 2000-02-29
EP0952149B1 (en) 2004-06-09
HU9901220A (hu) 2000-04-28
AR018186A1 (es) 2001-10-31
ZA992771B (en) 2002-04-18
EP0950657A2 (en) 1999-10-20
ID23287A (id) 2000-04-05
NZ335251A (en) 2000-11-24
YU19199A (sh) 2002-08-12
DK0950657T3 (da) 2004-11-22
JPH11322713A (ja) 1999-11-24
HU9901220D0 (en) 1999-06-28
ZA992772B (en) 2002-07-16
DE69918590D1 (de) 2004-08-19
TR199900853A2 (xx) 1999-11-22
BR9901279A (pt) 2000-05-02
AR018593A1 (es) 2001-11-28
NO314400B1 (no) 2003-03-17
CZ137099A3 (cs) 1999-11-17
CO5011054A1 (es) 2001-02-28
EA199900301A2 (ru) 1999-10-28
KR19990083232A (ko) 1999-11-25
HU9901221D0 (en) 1999-06-28
TR199900843A2 (xx) 2000-02-21
SG81976A1 (en) 2001-07-24
TWI238160B (en) 2005-08-21
CZ136999A3 (cs) 1999-11-17
PE20000476A1 (es) 2000-06-02
EP0950657A3 (en) 2001-08-16
SG81977A1 (en) 2001-07-24
CA2269262A1 (en) 1999-10-17
DZ2769A1 (fr) 2003-12-01
KR100586761B1 (ko) 2006-06-08
KR19990083233A (ko) 1999-11-25
NO991821L (no) 1999-10-18
EA002347B1 (ru) 2002-04-25
EA199900303A3 (ru) 2000-04-24
ID23761A (id) 2000-05-11

Similar Documents

Publication Publication Date Title
PT1124810E (pt) Derivados 2-amino-tiazole, processo para a sua preparacao e sua utilizacao como agentes anti-tumorais
BR9809112B1 (pt) processo para preparação de clopidogrel.
BR9915708B1 (pt) processo para preparação de monoariloxi-metalocenos.
PT1303478E (pt) Processo para a preparacao de alcanoilamidas substituidas
SI0950657T1 (en) Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
NO991982D0 (no) FremgangsmÕte ved hydrogenering
PT102130A (pt) Processo de preparacao de dihidrato de azitromicina
BR0013853B1 (pt) processo para identificar contornos de leito.
BR9701136A (pt) Processo para obtenção de isoforona
PT1313698E (pt) Processo para a preparacao de fenilacetonitrilos substituidos
PT923599E (pt) Processo para a preparacao de 17-esteres de 9alfa,21-di-halopregnano-11beta,17alfadiol-20-onas
PT1047665E (pt) Inibidores de metaloproteases de matriz
PT912603E (pt) Processo para preparar certos aza ciclo-hexapeptidos
BR0012217B1 (pt) processo de cozimento para polpa.
FI19992315L (fi) Menetelmä hillon valmistamiseksi
PT1200414E (pt) Processo para a preparacao de pirimidnas substituidas
BR9805538B1 (pt) processo para a preparação de ferro-succinilcaseìna.
PT1203000E (pt) Processo para producao de fosfonometilglicina
PT1053224E (pt) Bifenilsulfonilcianamida, processo para a sua preparacao e sua utilizacao como medicamento
AR027878A1 (es) Metodos para identificar y utilizar compuestos inhibidores de amiloides
PT1240173E (pt) Processo para a preparacao de n-fosfonometilglicina
DE69823002D1 (de) Verfahren zur Überwachung mehrerer Transaktionen
BR9814266B1 (pt) processo para a preparação de oxazafosforin-2-aminas.
PT974275E (pt) Proceso para esterilizacao